NCT04581473 2025-06-05
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
CARsgen Therapeutics Co., Ltd.
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT04415385 2020-06-04
The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT02726854 2016-12-02
Apslpanc
First Affiliated Hospital Xi'an Jiaotong University
Phase 2 Unknown
NCT02863367 2016-08-11
OECTAPGAMPC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown